NBTX

Nanobiotix S.A.

5.81 USD

Last updated Dec 8, 22:16 UTC

Yesterday HIGH

$5.96

Yesterday LOW

$5.6

52w HIGH

$11

52w LOW

$1.75

EPS

-0.87

PE

-6.68

Next Earnings

Apr 22, 2024

Overview News Government Trades

Nanobiotix S.A. stock is up 2.11% since 30 days ago. The next earnings date is Apr 22, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 3 December’s closed higher than November.

Nanobiotix S.A. focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer and non-small cell lung cancer.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

-

Website

nanobiotix.com

Happy Mohamed

Tue Aug 15, 2023

NANOBIOTIX Announces Expiration Of HSR Waiting Period Regarding The Agreement For Worldwide Co-Development And Commercialization Of Potential First-In-Class Radioenhancer NBTXR3

NANOBIOTIX (NASDAQ:NBTX), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announced today the expiration of the
Lisa Levin

Tue Jul 25, 2023

Rackspace Technology, AMC Entertainment And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures traded mixed this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session.
Lisa Levin

Mon Jul 24, 2023

Top 5 Health Care Stocks That May Collapse In July

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Lisa Levin

Thu Jul 20, 2023

Why Infosys Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Gainers PainReform Ltd. (NASDAQ: PRFX) jumped 45.5% to $10.34 after declining 8% on Wednesday. PaiReform recently regained compliance with Nasdaq continued listing requirements.
Lisa Levin

Thu Jul 20, 2023

Johnson & Johnson, Zions Bancorporation, Heritage-Crystal Clean And Other Big Stocks Moving Higher On Thursday

U.S. stocks traded mixed, with the Dow Jones gaining over 200 points on Thursday. Here are some big stocks recording gains in today’s session.
Benzinga Insights

Thu Jul 20, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Lisa Levin

Thu Jul 20, 2023

Why Nanobiotix Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

Gainers Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares surged 39.3% to $0.6621 in pre-market trading after gaining around 14% on Wednesday.
Bill Haddad

Wed Jul 19, 2023

NANOBIOTIX Announces First Patient Injected In New Phase 1/2 Study Evaluating Radiotherapy-Activated NBTXR3 Plus Anti-PD-1 For Patients With Advanced Cancers
Benzinga Insights

Mon Jul 10, 2023

12 Health Care Stocks Moving In Monday's Intraday Session
Lisa Levin

Mon Jul 10, 2023

Crude Oil Down 1%; Wholesale Inventories Unchanged For May

U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite trading slightly lower on Monday. The Dow traded up 0.42% to 33,875.27 while the NASDAQ fell 0.14% to 13,641.41. The S&P 500, also rose, gaining, 0.05% to 4,401.08.